PI
ROIV icon

PEAK6 Investments’s Roivant Sciences ROIV Stock Holding History

PEAK6 Investments’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$346K Buy
30,000
+1
+0% +$11 ﹤0.01% 2523
2024
Q2 		$317K Buy
+29,999
New +$329K ﹤0.01% 2508
2023
Q2 		– Sell
-66,934
Closed -$494K – 4589
2023
Q1 		$494K Buy
66,934
+14,577
+28% +$120K ﹤0.01% 2402
2022
Q4 		$418K Buy
52,357
+2,569
+5% +$14.3K ﹤0.01% 2678
2022
Q3 		$160K Buy
49,788
+44,787
+896% +$173K ﹤0.01% 3823
2022
Q2 		$20K Buy
+5,001
New +$19.9K ﹤0.01% 5737

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

PEAK6 Investments's ROIV Position: Q3 2024 in Review

PEAK6 Investments increased its Roivant Sciences (ROIV) stake by 0% in Q3 2024, buying an estimated $11 and bringing the position to 30,000 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #2523.

PEAK6 Investments first reported a position in ROIV in Q2 2022 and has held it in 6 quarters since. The position peaked at $494K in Q1 2023. 293 funds tracked by Wall St. Rank hold ROIV as of Q3 2024.

  • PEAK6 Investments held 30,000 shares of Roivant Sciences worth $346K as of Q3 2024.
  • PEAK6 Investments bought 1 Roivant Sciences share in Q3 2024, an estimated $11.
  • Roivant Sciences made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2523 holding.
  • PEAK6 Investments first reported a position in Roivant Sciences in Q2 2022 and has held it in 6 quarters since.
  • PEAK6 Investments's Roivant Sciences position peaked at $494K in Q1 2023.
  • 293 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.